tiprankstipranks
Trending News
More News >
Shofu Inc. (JP:7979)
:7979
Japanese Market

Shofu Inc. (7979) AI Stock Analysis

Compare
0 Followers

Top Page

JP:7979

Shofu Inc.

(7979)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 4o)
Rating:69Neutral
Price Target:
¥2,079.00
▲(11.18% Upside)
Shofu Inc. demonstrates strong financial performance with robust revenue growth and profitability, contributing significantly to the overall score. However, technical analysis indicates a bearish trend, and the valuation is fair but not exceptional. The absence of earnings call data and corporate events limits further insights.
Positive Factors
Revenue Growth
The significant revenue growth indicates robust demand for Shofu's products, enhancing its market position and supporting long-term business expansion.
Balance Sheet Health
A strong balance sheet with low leverage reduces financial risk and provides flexibility for strategic investments and growth opportunities.
Profitability
High profitability margins reflect operational efficiency and pricing power, supporting sustainable earnings and competitive advantage.
Negative Factors
Earnings Growth
Negative EPS growth suggests challenges in translating revenue growth into earnings, potentially impacting investor confidence and valuation.
Free Cash Flow Sustainability
Unsustainable free cash flow growth could lead to future liquidity issues, affecting the company's ability to fund operations and investments.
Return on Equity
While ROE is positive, there is room for improvement to enhance shareholder returns and align with industry benchmarks.

Shofu Inc. (7979) vs. iShares MSCI Japan ETF (EWJ)

Shofu Inc. Business Overview & Revenue Model

Company DescriptionShofu Inc. manufactures and sells dental materials and equipment worldwide. Its products include artificial teeth, dental porcelains, dental abrasives and polishers, dental alloys, dental cements, restorative materials, dental waxes, dental investments/stones, orthodontic devices, and preventive infection control goods. The company was formerly known as Shofu Dental Mfg. Co., Ltd. and changed its name to Shofu Inc. in 1983. Shofu Inc. was founded in 1922 and is based in Kyoto, Japan.
How the Company Makes MoneyShofu Inc. generates revenue primarily through the sale of its dental products and equipment to dental clinics, laboratories, and distributors worldwide. The company's revenue model is based on direct sales, as well as partnerships with dental distributors who help market and sell its products. Key revenue streams include sales of restorative materials, orthodontic products, and dental imaging technologies. Additionally, Shofu invests in research and development to innovate new products, which can lead to higher demand and sales. Strategic partnerships with dental professionals and educational institutions also enhance its market presence and contribute to its earnings.

Shofu Inc. Financial Statement Overview

Summary
Shofu Inc. exhibits strong financial health with impressive revenue growth and profitability. The balance sheet is robust with low leverage, and cash flows are solid, though the sustainability of free cash flow growth should be watched. The company is well-positioned in the medical instruments and supplies industry, with a stable financial foundation and growth potential.
Income Statement
Shofu Inc. has demonstrated strong revenue growth with a 45.7% increase in the latest year, indicating robust demand for its products. The company maintains healthy profitability with a gross profit margin of 59.4% and a net profit margin of 11.2%. EBIT and EBITDA margins are also solid at 15.9% and 18.7%, respectively, showcasing operational efficiency. Overall, the income statement reflects a positive growth trajectory and strong profitability.
Balance Sheet
The balance sheet of Shofu Inc. is stable with a low debt-to-equity ratio, indicating minimal leverage and financial risk. The return on equity is 10.1%, reflecting effective use of shareholder funds to generate profits. The equity ratio stands at 85.3%, suggesting a strong capital structure. While the company is financially sound, the ROE could be improved to enhance shareholder returns.
Cash Flow
Shofu Inc. shows a strong operating cash flow to net income ratio of 0.66, indicating efficient cash generation from operations. The free cash flow to net income ratio is 0.64, reflecting good cash conversion. However, the free cash flow growth rate is extremely high due to a low base effect, which may not be sustainable. Overall, the cash flow position is healthy but requires monitoring for consistency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue38.75B38.70B35.08B31.68B28.14B24.68B
Gross Profit23.09B22.99B21.00B18.70B16.17B13.60B
EBITDA6.99B7.23B6.47B5.40B4.52B3.26B
Net Income4.05B4.32B3.65B3.13B2.55B1.67B
Balance Sheet
Total Assets50.18B49.99B50.09B43.73B40.71B37.81B
Cash, Cash Equivalents and Short-Term Investments9.96B10.89B9.72B9.58B9.06B6.94B
Total Debt1.87B213.00M281.00M1.19B1.48B1.87B
Total Liabilities7.51B7.26B8.48B8.21B7.77B7.62B
Stockholders Equity42.58B42.66B41.53B35.44B32.87B30.14B
Cash Flow
Free Cash Flow0.002.22B1.38B1.54B2.67B1.73B
Operating Cash Flow0.003.45B3.09B3.17B3.74B2.83B
Investing Cash Flow0.00-914.00M-1.29B-1.29B-1.29B-4.08B
Financing Cash Flow0.00-1.78B-2.10B-1.46B-1.07B3.02B

Shofu Inc. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price1870.00
Price Trends
50DMA
1838.80
Positive
100DMA
1893.94
Negative
200DMA
1966.09
Negative
Market Momentum
MACD
2.13
Negative
RSI
60.84
Neutral
STOCH
90.59
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7979, the sentiment is Neutral. The current price of 1870 is above the 20-day moving average (MA) of 1826.25, above the 50-day MA of 1838.80, and below the 200-day MA of 1966.09, indicating a neutral trend. The MACD of 2.13 indicates Negative momentum. The RSI at 60.84 is Neutral, neither overbought nor oversold. The STOCH value of 90.59 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7979.

Shofu Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥49.30B11.673.22%12.92%29.48%
74
Outperform
¥122.10B23.555.97%1.78%3.17%7.07%
69
Neutral
¥66.73B14.612.83%3.69%1.86%
68
Neutral
¥145.61B31.362.73%5.10%-26.13%
67
Neutral
¥17.65B12.832.65%0.81%-26.76%
59
Neutral
¥144.24B257.570.78%1.31%-2.06%-79.17%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7979
Shofu Inc.
1,870.00
-213.61
-10.25%
JP:3593
Hogy Medical Co
6,690.00
1,879.77
39.08%
JP:7780
Menicon Co
1,605.00
301.32
23.11%
JP:5889
Japan Eyewear Holdings Co.,Ltd.
2,043.00
-165.59
-7.50%
JP:7730
Mani, Inc.
1,478.00
14.96
1.02%
JP:7743
Seed Co., Ltd.
583.00
88.46
17.89%

Shofu Inc. Corporate Events

Shofu Streamlines Shareholder Benefits and Adjusts Discounted Product Pricing
Dec 22, 2025

Shofu Inc. has announced partial amendments to its shareholder benefits plan, primarily to streamline operations and align logistics, by unifying the shipment period for complimentary company products to late June each year. The company is also revising the preferential pricing within the shareholder plan for its medicated liquid toothpaste “Hapica Ace” in line with a broader price revision, while maintaining the range of eligible shareholders and the core lineup of dental care products offered at discounted rates, a move aimed at improving administrative efficiency and sustaining the attractiveness of its benefits program for investors.

The most recent analyst rating on (JP:7979) stock is a Hold with a Yen2079.00 price target. To see the full list of analyst forecasts on Shofu Inc. stock, see the JP:7979 Stock Forecast page.

Shofu Sets 2040 “Vision10” to Join Global Top 10 Dental Companies
Dec 19, 2025

Shofu Group has unveiled a new long-term vision, “Vision10,” targeting a position among the world’s top 10 dental companies by 2040 with group revenue of ¥250 billion and an operating margin of 20%. Building on its current medium-term plan and responding to structural shifts in the global dental industry—such as demographic change, rising preventive care, and digitalization—the company plans to strengthen its foundation in restorative materials, accelerate global expansion in areas including digital dentistry, preventive and oral care, and orthodontics, and move into adjacent fields such as periodontal care, regenerative medicine, and education, with the aim of transforming its growth profile and deepening its contribution to global dental healthcare.

The most recent analyst rating on (JP:7979) stock is a Hold with a Yen2079.00 price target. To see the full list of analyst forecasts on Shofu Inc. stock, see the JP:7979 Stock Forecast page.

Shofu Inc. Announces Key Personnel Changes for 2026
Dec 10, 2025

Shofu Inc. announced a personnel change effective January 1, 2026, with Shinya Teramoto being appointed as Managing Executive Officer, Personnel and General Affairs, and General Manager of the General Affairs Department. This change reflects the company’s ongoing efforts to strengthen its leadership team and enhance operational efficiency.

The most recent analyst rating on (JP:7979) stock is a Hold with a Yen2079.00 price target. To see the full list of analyst forecasts on Shofu Inc. stock, see the JP:7979 Stock Forecast page.

Shofu Inc. Reports Modest Sales Growth Amid Increased R&D Investment
Nov 6, 2025

Shofu Inc. reported a slight increase in consolidated net sales for the first half of the fiscal year ending March 2026, with a 1.1% year-over-year growth. The dental business remains a major contributor to sales, although there was a minor decline in overseas sales. The company also noted a significant increase in R&D expenses, indicating a focus on innovation and product development.

The most recent analyst rating on (JP:7979) stock is a Hold with a Yen2079.00 price target. To see the full list of analyst forecasts on Shofu Inc. stock, see the JP:7979 Stock Forecast page.

Shofu Inc. Reports Mixed Financial Results for H1 2025
Nov 6, 2025

Shofu Inc. reported its consolidated financial results for the six months ending September 30, 2025, showing a slight increase in net sales by 1.1% to 19,095 million yen. However, operating income decreased by 7.5% compared to the previous year. The company experienced a significant rise in comprehensive income by 313.2% to 2,896 million yen, indicating improved profitability despite the decline in operating income. The company also noted a two-for-one stock split, affecting the calculation of earnings per share. The financial outlook for the fiscal year ending March 31, 2026, projects a 5.6% increase in net sales, with a slight decrease in operating and ordinary income, but an 8.9% increase in net income attributable to owners of the parent.

The most recent analyst rating on (JP:7979) stock is a Hold with a Yen2079.00 price target. To see the full list of analyst forecasts on Shofu Inc. stock, see the JP:7979 Stock Forecast page.

Shofu Inc. Revises Earnings Forecast Amid Market Challenges
Oct 28, 2025

Shofu Inc. has revised its earnings forecast for the first half of the fiscal year ending March 31, 2026, due to lower-than-expected demand in Japan and challenging overseas business conditions. Despite a decrease in net sales, the company anticipates higher operating and ordinary income due to deferred expenses and increased net income from the early sale of cross-shareholdings. The full-year earnings forecast remains unchanged, with the company aiming to maintain profitability while monitoring the business environment.

The most recent analyst rating on (JP:7979) stock is a Buy with a Yen2171.00 price target. To see the full list of analyst forecasts on Shofu Inc. stock, see the JP:7979 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 29, 2025